Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
TAK-875 Versus Placebo or Glimepiride in Type 2 Diabetes Mellitus: | |
|
| |
New drug targets have been under research in order to explore
alternative drugs to promote insulin secretion in patients with type-2 diabetes
mellitus. One of the most researched targets amongst these is the G-protein
coupled receptor-40 (GPCR-40) or free-fatty acid receptor-1 (FFAR1). GPCR-40 or
the FFAR1 is found in the pancreatic β-cells,
which secrete insulin.
The FFAR1 receptors are activated by short and long-chain free fatty acids. Thus, they are activated when the free fatty acid levels in the blood are high, for example, after a meal. The activation results in insulin secretion. The FFAR1 receptors have been explored as a target for the treatment of diabetes
A phase-2 clinical trial was recently completed which assessed the potential of TAK-875 in achieving control of blood glucose levels without causing hypoglycemia or low sugar levels TAK-875 brings about its action by the activation of FFAR1 receptors.
Four hundred and twenty six patients with type-2 diabetes mellitus were included in this study. These were patients who did not respond to diet or metformin. The patients were divided randomly into three study groups: the first group which received TAK-875, the second group received glimepiride 4 mg once daily and the third group received placebo for over a period of twelve weeks.
The achievement of glycaemic control was measured using the gylcosylated haemoglobin percentage (HbA1c) from the baseline till the end of the study.
A significant reduction in HbA1c was observed by the researchers in the group receiving TAK-875.
The researchers also observed that hypoglycemic events were reported to be higher in the group receiving glimepiride as compared to placebo or TAK-875.
The researchers thus concluded that activation of FFAR1 is a viable therapeutic target for the treatment of type 2 diabetes mellitus.
Source-Medindia
| |
|
|
More News on: Diabetic Retinopathy, Diabetes, Diabetic Diet, Otitis Media, Diabetes - Essentials, Diabetes - Self-Monitoring of Blood Glucose (SMBG), Amoebic Dysentery, Insulin Delivery Devices, Diabetes and Exercise, Stress Relief Through Alternative Medicine
 Comment & Contribute
|
Related Links
Type 2 Diabetes
Globalization and changing lifestyles has made diabetes very common in developing countries so much so that India is known as the Diabetes Capital of ...
Diabetes Risk Assessment Calculator
Almost one-third of the people are unaware of the risk factors of diabetes. Find out if you run the risk of diabetes by using Diabetes Risk ...
Can Surgical Treatment Help Patients With Type 2 Diabetes Mellitus?
Either decreased production of insulin or increased resistance to it from peripheral tissues or both factors combined together leads to diabetes. ...
Health In Focus News
Strenuous Working Environment Leads to Diabetes
According to the scientists working in strenuous environment, healthy individuals too are exposed to the threat of developing diabetes. ...
Discarded Kidneys Can Be Used to Generate New Kidneys for Transplantation - Dawn of a New Era in Regenerative Medicine Research
Researchers at Wake Forest Baptist Medical Center in the USA found that human kidneys discarded for transplant can potentially serve as a ...
Flavored Toothbrush for a Pleasant Morning
Toothbrushes are all set to take up a new role. They may soon deliver your morning coffee and get you up and alert even faster. Even more ...
Science Behind the Placebo Effect
Probably the most controversial, yet amazing aspect of medicine is the placebo effect. The idea that somehow, a simple sugar pill, or a drugless ...
Exposure to Toxic Waste can Ruin Health in Kids
Children dwelling at places with abundance of toxic waste in Indonesia, India and Philippines may develop high quantities of lead in their blood ...
Media Reports on Health Hazards May Affect the Health of Some People
Media reports on the adverse effects of substances or technologies can actually trigger the symptoms in some people who read the report, even ...
- Health News Index
 | Quiz on Diabetes Are you at risk for diabetes? To find out check out our health quiz. 
|
- News Quick Links
 |
Diabetes
Complete Medindia Resources
|
| News Categories: |
| » | Researchers Say Timing of Cancer Radiation Therapy May Minimize Hair Loss |
| » | Mechanism Linking Key Inflammatory Marker to Cancer Found By Researchers |
| » | Study Highlights RNA-Based Classification System for Colorectal Cancer |
| » | Research Highlights Racial Disparities in the Surgical Management of Non-Small Cell Lung Cancer |
| » | Bike Chain Fitted into Cancerous Jaw Saves Life of Single Mum |
| More Cancer News | |
|
Ask an Expert
